The Efficacy and The Safety of Ultrasound-guided Ablation Therapy for Treating Papillary Thyroid Microcarcinoma

The prevalence of papillary thyroid microcarcinoma (PTMC) increases rapidly all around the world, but the management of PTMC hasn't reached a consensus. Recently, ultrasound-guided (US-guided) ablation therapy was introduced as a feasible treatment for low-risk PTMC. The clinical application of...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Cancer 2019-01, Vol.10 (21), p.5272-5282
Main Authors: Chen, Jifan, Cao, Jing, Qiu, Fuqiang, Huang, Pintong
Format: Article
Language:English
Subjects:
Ablation
Biopsy
Cancer therapies
Clinical medicine
Disease
Hospitals
Lasers
Medical prognosis
Medical research
Patients
Review
Thyroid cancer
Tumors
Ultrasonic imaging
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prevalence of papillary thyroid microcarcinoma (PTMC) increases rapidly all around the world, but the management of PTMC hasn't reached a consensus. Recently, ultrasound-guided (US-guided) ablation therapy was introduced as a feasible treatment for low-risk PTMC. The clinical application of US-guided ablation therapy needs doctors' effort to investigate the efficacy and the safety of US-guided ablation in treating PTMC carefully. Although the present evidence showed some limitations, such as short-term study time spans and no randomized control design, in our perspective, US-guided thermal ablation therapy has good short-term efficacy and safety and is a promising PTMC's treatment in future clinical practice.
ISSN:1837-9664
1837-9664
DOI:10.7150/jca.36289